FDA Deploys Agency-Wide AI Tool to Accelerate Scientific Reviews
TL;DR Summary
The FDA has launched an agencywide generative AI tool called Elsa to streamline scientific reviews, support drug safety assessments, and improve efficiency, while emphasizing secure data handling within Amazon Web Services' GovCloud environment. Concerns remain about data security and the speed of AI integration into the agency's workflow.
- FDA launches agencywide AI tool Axios
- FDA Launches Agency-Wide AI Tool to Optimize Performance for the American People fda.gov
- How GenAI is already transforming regulatory writing for the life sciences Regulatory Affairs Professionals Society | RAPS
- US FDA launches AI tool to reduce time taken for scientific reviews Reuters
- FDA rolls out AI tool agency-wide, weeks ahead of schedule statnews.com
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 2 min read
Condensed
86%
351 → 48 words
Want the full story? Read the original article
Read on Axios